Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML

NCT02306291 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia, Myeloid, Acute

Interventions

DRUG: GMI-1271
DRUG: Mitoxantrone
DRUG: Etoposide
DRUG: Cytarabine
DRUG: Idarubicin

Sponsor

GlycoMimetics Incorporated